Caterease Tutorial Videos - Search Videos

Genentech's Giredestrant: First Oral SERD for Breast Cancer Survival

Genentech's Giredestrant: First Oral SERD for Breast Cancer Survival

104 views7 months ago

YouTubeMCQ Pedia

lidERA trial: giredestrant improves invasive disease-free survival in ER+/HER2- early breast cancer

lidERA trial: giredestrant improves invasive disease-free survival in ER+/HER2- early breast cancer

1K views10 months ago

YouTubeVJOncology

New Oral SERD Improves Outcomes in Adjuvant Breast Cancer Treatment

New Oral SERD Improves Outcomes in Adjuvant Breast Cancer Treatment

101 views6 months ago

YouTubeThe Oncology Brief

Giredestrant plus everolimus new treatment option in ER+, HER2– advanced breast cancer, post-CDK...

Giredestrant plus everolimus new treatment option in ER+, HER2– advanced breast cancer, post-CDK...

352 views8 months ago

Let’s talk about lidERA trial which was presented at SABCS! This study tested whether the oral SERD (selective estrogen receptor degrader), giredestrant, is superior to current endocrine therapy as adjuvant therapy in ER /HER2 negative early stage breast cancer. Giredestrant binds to the estrogen receptor and induces a change in it that not only blocks the estrogen receptor but breaks it down as well. SERDs are approved in metastatic breast cancer but this is the first study in early stage breas

Let’s talk about lidERA trial which was presented at SABCS! This study tested whether the oral SERD (selective estrogen receptor degrader), giredestrant, is superior to current endocrine therapy as adjuvant therapy in ER /HER2 negative early stage breast cancer. Giredestrant binds to the estrogen receptor and induces a change in it that not only blocks the estrogen receptor but breaks it down as well. SERDs are approved in metastatic breast cancer but this is the first study in early stage breas

24.4K views10 months ago

FacebookEleonora Teplinsky, MD

lidERA: giredestrant efficacy by menopausal status in ER+/HER2- breast cancer

lidERA: giredestrant efficacy by menopausal status in ER+/HER2- breast cancer

265 views4 months ago

YouTubeVJOncology

What is Giredestrant? A Revolution in Hormone-Positive Breast Cancer Treatment 🎉 Coming Soon! 👯 C...

What is Giredestrant? A Revolution in Hormone-Positive Breast Cancer Treatment 🎉 Coming Soon! 👯 C...

29.7K views2 weeks ago

YouTube닥터BTS의 유선방송

New Oral SERD Shows Promise in Early Breast Cancer Treatment

26 views6 months ago

YouTubeOncology Perspectives

Dr. Amit Garg 🩸 on Instagram: "Roche revealed that giredestrant — an oral selective-estrogen receptor degrader (SERD) — cut the risk of breast-cancer recurrence by 30% compared with standard endocrine therapy in early-stage disease #cancer #breastcancer"

91.2K views10 months ago

Instagramblooddocdad

A major update from SABCS: BCRF investigator Dr. Aditya Bardia shares encouraging results from the lidERA trial, studying a new hormone therapy called giredestrant for early HR breast cancer. In the trial, giredestrant lowered the risk of cancer coming back and showed fewer treatment-related side effects, meaning it may be both more effective and easier to stay on than current options. If approved, it could become the first new adjuvant endocrine therapy in decades. FDA review is expected in 202

11.4K views10 months ago

FacebookThe Breast Cancer Research Foundation

Replying to @Vicky 🎥 Can you switch from anastrozole to giredestrant? So many of you asked this — especially those in surgical menopause currently taking aromatase inhibitors like anastrozole. Here’s what we know so far ⬇️ 🧬 Giredestrant is a new oral SERD (Selective Estrogen Receptor Degrader) that’s being studied as initial adjuvant therapy — meaning it was started shortly after surgery, not as a switch from anastrozole. As of now, there’s no trial data on whether it’s safe or effective to s

1.7K views9 months ago

TikTokjasvir.kaur.pharmd

Are Oral SERDs Better Than Standard Therapy in Breast Cancer?

130 views5 months ago

YouTubeCancerNetwork

Combining Ribociclib & Abemaciclib with Giredestrant - More Data Needed?

97 views5 months ago

YouTubeInnovative Oncology News

62% Improvement in PFS – evERA Breast Cancer Study Update

442 views11 months ago

YouTubeTargeted Oncology

Oral SERDs Impacting Breast Cancer Treatment #shorts

381 views8 months ago

YouTubeCancer Treatment Updates

🚨 Roche Reports evERA Phase III Trial | Can Giredestrant + Everolimus Change Breast Cancer Care?

389 viewsSep 25, 2025

YouTubeOncoAlert 360

EMPRESS: giredestrant vs tamoxifen in ER+/HER2- early breast cancer

185 views11 months ago

YouTubeVJOncology

Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic bre...

25 views2 months ago

Giredestrant vs Standard-of-Care Endocrine Therapy as Adjuvant Treatment for Patients with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer: Results From the Global Phase III lidERA Breast Cancer Trial | OncLive

Trending in Women’s Health: Giredestrant, Iza-bren and More

3 views4 months ago

YouTubeLucidQuest

PREcoopERA: Are endocrine therapy strategies changing with giredestrant?

41 views4 months ago

YouTubeOncoInfoTV

Early Stage Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Erica Mayer

7.6K views8 months ago

YouTubeOncBrothers: Practice-Changing Cancer Discussions

How to treat GERD

3.2K views10 months ago

YouTubeLoyola Medicine

HR+ Breast Cancer: Inavolisib First -Line Use and Emerging Adjuvant Oral SERDs

1.3K views9 months ago

YouTubeOncUpdates: Latest Oncology Insights

3 Breast Cancer Trials That Will Change Care in 2026

4.7K views9 months ago

YouTubeCancer Treatment Updates

PREcoopERA: giredestrant versus anastrozole in ER+/HER2- early breast cancer

403 viewsMay 17, 2024

YouTubeVJOncology

Giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausal, HER2-negative...

1.5K viewsSep 30, 2021

Women's Health Update – 10 Jun 2026: Giredestrant, Iza-bren and More

16 views4 months ago

YouTubeLucidQuest

Oncology Update – 02 Mar 2026: FDA Full Approval for BRAFTOVI, FDA Accepts Giredestrant NDA and More

31 views7 months ago

YouTubeLucidQuest

ASCO 2026 — Breast & GU Cancer Top Trials

111 views4 months ago

YouTubeCancer Care Tools

See more